266 results on '"Grisoli, Marina"'
Search Results
2. Tracking longitudinal thalamic volume changes during early stages of SCA1 and SCA2
3. Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study)
4. Intraoperative Comparison Between Strain Elastography and Preoperative Magnetic Resonance Imaging Features in High-Grade Gliomas Using Fusion Imaging: A Pilot Study
5. A surgery-informed precision approach to determining brain targets for real-time fMRI neurofeedback modulation in chronic pain
6. The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy
7. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
8. The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components.
9. Bilateral Simultaneous Magnetic Resonance–Guided Focused Ultrasound Pallidotomy for Life‐Threatening Status Dystonicus.
10. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study
11. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
12. Focused ultrasound therapy in movement disorders: management roadmap toward optimal pathway organization
13. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study
14. New MAPT variant in a FTD patient with Alzheimer’s disease phenotype at onset
15. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
16. Correction to: The cognitive phenotypes of Creutzfeldt‑Jakob disease: comparison with secondary metabolic encephalopathy
17. Cortical network dysfunction revealed by magnetoencephalography in carriers of spinocerebellar ataxia 1 or 2 mutation
18. Resting‐state fMRI functional connectome of C9orf72 mutation status
19. Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
20. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort
21. The optimal targeting for focused ultrasound thalamotomy differs between dystonic and essential tremor. A 12‐month prospective pilot study
22. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease
23. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study
24. ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype
25. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene
26. Complex Ataxia‐Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia
27. A discriminative event‐based model for subtype diagnosis of sporadic Creutzfeldt‐Jakob disease using brain MRI
28. A discriminative event-based model for subtype diagnosis of sporadic Creutzfeldt-Jakob disease using brain MRI
29. Letter to the editor: A case of functional isolated tongue tremor-like dyskinesia after COVID-19 vaccine
30. Letter to the editor: A case of functional isolated tongue tremor–like dyskinesia after COVID‐19 vaccine
31. D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study
32. Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study
33. Comparison of arterial spin labeling registration strategies in the multi‐center GENetic frontotemporal dementia initiative (GENFI)
34. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA‐binding protein 43 inclusions) in missense progranulin mutation Cys139Arg
35. Role of CT and MRI in Diagnosis and Research
36. Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome
37. Degenerative Diseases
38. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study
39. Decision-making under risk: A graph-based network analysis using functional MRI
40. Pain related to MRgFUS: a merely minor transient adverse event?
41. Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease
42. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6
43. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort
44. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
45. Neural Signatures of Economic Parameters During Decision-Making: A Functional MRI (fMRI), Electroencephalography (EEG) and Autonomic Monitoring Study
46. Biexponential and diffusional kurtosis imaging, and generalised diffusion-tensor imaging (GDTI) with rank-4 tensors: a study in a group of healthy subjects
47. Loss of heterozygosity studies in extracranial metastatic meningiomas
48. Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging
49. Progression of Cerebellar Atrophy in Spinocerebellar Ataxia Type 2 Gene Carriers: A Longitudinal MRI Study in Preclinical and Early Disease Stages
50. New MAPT variant in a FTD patient with Alzheimer’s disease phenotype at onset
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.